DJIA 17,730.11 0.00 0.00%
NASDAQ 5,009.21 0.00 0.00%
S&P 500 2,076.78 0.00 0.00%
market minute promo

507.70 -3.38 (-0.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

REGN $507.70 -0.66%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $511.08
Daily Range $0.00 - $0.00
52-Week Range $295.76 - $544.00
Market Cap $52.4B
P/E Ratio 163.81
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 764,914
Current FY EPS $7.81

Sector

Healthcare

Industry

Drug Makers

Regeneron Pharmaceuticals, Inc. (REGN) Description

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions. Website: http://www.regeneron.com/

News & Commentary Rss Feed

Why Avalanche Biotechnologies, Inc. Stock Collapsed Today

Avalanche Biotechnologies saw its share price plummet today on exceptional volume. Here's why.

Why Praluent Could Be Blockbuster For Regeneron

Is Avalanche Biotechnologies A Good Buy Now After Phase 2 Results For Its Wet AMD Drug?

IBB, CELG, AMGN, REGN: Large Inflows Detected at ETF

What Is Beyond Vision-Loss Blockbuster For Regeneron?

Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion

Regeneron/Bayer's Eylea Gets Label Expansion in Japan - Analyst Blog

Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the N

Regeneron Rapid Response Platform for Emerging Infectious Diseases Described in Proceedings of the National Academy of Sciences Publication

Is It Time to Stop Chasing Netflix Higher?

Regeneron's Growth Governed By 3 Key Prospects

3 Stocks Advancing The Health Care Sector

See More REGN News...

REGN's Top Competitors

REGN $507.70 (-0.66%)
Current stock: REGN
AMGN $153.18 (-0.05%)
Current stock: AMGN
GILD $115.04 (0.00%)
Current stock: GILD
BIIB $404.28 (0.00%)
Current stock: BIIB